EP2533047 - Bibliographic data

CCR4 EN TANT QUE CIBLE THÉRAPEUTIQUE POUR LE CANCER

Last update	06/07/2025
Legal status	Brevet déchu
Origin	Européen

(73) Holder	CANCER RESEARCH TECHNOLOGY LIMITED Angel Building 407 St John Street London EC1V 4AD Royaume-Uni
(72) Inventors	Violet Slettenaar Barts Cancer Institute Queen Mary University of London Charterhouse Square London EC1M 6BQ Royaume-Uni Julia Wilson Barts Cancer Institute Queen Mary University of London Charterhouse Square London EC1M 6BQ Royaume-Uni Yaohe Wang Barts Cancer Institute Queen Mary University of London Charterhouse Square London EC1M 6BQ Royaume-Uni Tiziana Schioppa Barts Cancer Institute Queen Mary University of London Charterhouse Square London EC1M 6BQ Royaume-Uni Frances Balkwill Barts Cancer Institute Queen Mary University of London Charterhouse Square London EC1M 6BQ Royaume-Uni
(74) Agent	Mail recipient RIGBY, BARBARA NICOLE Dehns St Bride's House 10 Salisbury Square London EC4Y 8JD Royaume-Uni

(21) Request number	EP12182790.1
(22) Request date	18/09/2008

(11) Publication number	EP2533047
Publication date	11/05/2016

(54) Title of the invention	CCR4 EN TANT QUE CIBLE THÉRAPEUTIQUE POUR LE CANCER
(51) International classification	G01N 33/50, G01N 33/574, A61K 31/00
International classification (before reform)	None

Claimed priority	(31) Number: 0718167 (32) Date: 18/09/2007 (33) Country: GB
Initial application	None
Divisional application	None

Expected annuity	Annuity: 9 - Amount: 120 € - Due date 30/09/2016 Surtax: 9 - Amount: 24 € - Due date 03/04/2017
Last annuity	None

Publication	BREVETS D'INVENTION DESIGNANT MC DELIVRES PAR l'OEB - bulletin 2016/30, of 29/07/2016
History	Publication de la délivrance du brevet européen - Legal date 11/05/2016 Entrée en période de grâce du brevet d'invention - Legal date 01/10/2016 Déchéance du brevet d'invention après période de grâce - Legal date 30/09/2016